This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (5)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Immunologic Disorders  • Bone Marrow Transplantation  • Alert me on articles by topic

Arch Dermatol. 2000;136:779-780.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

DERMATOLOGISTS PERFORM skin biopsies to, among other reasons, determine whether to initiate or maintain therapy. In an attempt to address the value of a skin biopsy in the decision to initiate therapy, Zhou and colleagues,¹ in this issue of the Archives of Dermatology, present a study analyzing the usefulness of skin biopsies in the management of acute graft-vs-host disease (GVHD) following allogeneic bone marrow transplantation. In their retrospective study of 88 patients, 51 patients underwent a skin biopsy to confirm or rule out the diagnosis of acute GVHD. The biopsy results were available for only 5 patients at the time of initiation of therapy for acute GVHD, and of these patients, there were only 2 for whom the decision to treat was based primarily on the biopsy results. The authors found no statistically significant association between whether a person received treatment and whether they had a positive or a . . . [Full Text of this Article]

RELATED ARTICLE

Clinical Significance of Skin Biopsies in the Diagnosis and Management of Graft-vs-Host Disease in Early Postallogeneic Bone Marrow Transplantation
Youwen Zhou, Michael J. Barnett, and Jason K. Rivers
Arch Dermatol. 2000;136(6):717-721.
ABSTRACT | FULL TEXT